Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients

These findings suggest that low Dicer mRNA levels seem to be independent predictors of favourable outcome and response in patients affected by advanced CRCs treated with Bevacizumab-based therapy.